Epidemiologic pattern of cancers in Iran; current knowledge and future perspective
Iran is a developing country facing demographic transition. Cancers are among the major
non-communicable disorders with remarkable budern on the health-care governing …
non-communicable disorders with remarkable budern on the health-care governing …
Oncometabolites as biomarkers in thyroid cancer: a systematic review
Introduction Thyroid cancer (TC) is an important common endocrine malignancy, and its
incidence has increased in the past decades. The current TC diagnosis and classification …
incidence has increased in the past decades. The current TC diagnosis and classification …
Childhood cancer in Iran
SM Mousavi, A Pourfeizi, S Dastgiri - Journal of pediatric …, 2010 - journals.lww.com
This study tries to define the incidence, survival, and risk factors of childhood cancer in Iran.
A literature review on published articles was conducted by using different search engine …
A literature review on published articles was conducted by using different search engine …
The 15-year national trends of endocrine cancers incidence among Iranian men and women; 2005–2020
Cancer is one of the important health problems in Iran, which is considered as the third
cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most …
cause of death. Endocrine cancers are rare but mostly curable. Thyroid cancer, the most …
A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries
Based on GLOBOCAN 2012, cancers have led to more than 14 million new cases and over
8 million deaths worldwide. The fraction of developing nations is estimated to be 56.9% for …
8 million deaths worldwide. The fraction of developing nations is estimated to be 56.9% for …
[HTML][HTML] Liquid biopsy in thyroid cancer: new insight
F Khatami, SM Tavangar - … of hematology-oncology and stem cell …, 2018 - ncbi.nlm.nih.gov
Thyroid cancer, one of the most widespread malignancies of the endocrine-related system
that over the past three decades, has a vivid increasing rate. The diagnosis and …
that over the past three decades, has a vivid increasing rate. The diagnosis and …
Personalized treatment options for thyroid cancer: current perspectives
Thyroid cancer is one of the most common endocrine malignancies, with increasing
incidence all over the world. In spite of good prognosis for differentiated thyroid carcinoma …
incidence all over the world. In spite of good prognosis for differentiated thyroid carcinoma …
Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAFV600E mutation as biomarkers for papillary thyroid carcinoma
F Khatami, B Larijani, R Heshmat… - Journal of cellular …, 2020 - Wiley Online Library
Circulating cell‐free DNA (cfDNA) has been considered as a diagnostic source to track
genetic and epigenetic alterations in cancer. We aimed to study mutation in addition to the …
genetic and epigenetic alterations in cancer. We aimed to study mutation in addition to the …
National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019
M Azangou-Khyavy, S Saeedi Moghaddam… - Scientific reports, 2022 - nature.com
An updated exploration of the burden of thyroid cancer across a country is always required
for making correct decisions. The objective of this study is to present the thyroid cancer …
for making correct decisions. The objective of this study is to present the thyroid cancer …
Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer
Promoter methylation in a number of tumor-suppressor genes (TSGs) can play crucial roles
in the development of thyroid carcinogenesis. The focus of the current meta-analysis was to …
in the development of thyroid carcinogenesis. The focus of the current meta-analysis was to …